Menu

Imperial Innovations portfolio of companies

Imperial Innovations has a portfolio made up of 93 companies (as at 31 January 2014) covering a range of sectors, but primarily in the areas of therapeutics, medtech, engineering and ICT. Innovations manages its portfolio of companies actively, taking a seat on the board of companies it invests in and providing guidance on management recruitment, intellectual property strategy and overall company development.

The top thirty companies in Imperial Innovations portfolio by value represent 98.5% of the total value of the portfolio, and the top 20 companies set out in the table below represent 94.7% of the Group's portfolio value. This top group of companies, in addition to newly founded and seed-funded companies, is the primary focus of our active portfolio management.

Top 20 companies by value


Company

Net Investment Carrying Value* (£ '000)

% issued share capital held*

Circassia 78,359 14.0%
Nexeon 34,086 40.0%
Veryan Medical 18,109 44.0%
Abzena 17,998 23.6%
Plaxica 9,446 45.7%
Cell Medica 7,979 25.2%
PsiOxus Therapeutics 7,892 26.7%
Oxford Immunotec 7,817 4.7%
Stanmore Implants 6,268 16.4%
Econic Technologies 6,145 56.1%
Autifony 6,060 25.7%
TopiVert 5,955 33.1%
Cortexica 5,428 30.0%
EVO Electric 3,786 34.1%
Cambrige Communication Systems 3,672 9.0%
Crescendo Biologics 3,250 17.4%
Mission Therapeutics 2,974 20.0%
Just Yoyo 2,857 36.2%
Nascient 2,750 78.8%
Abingdon Health 3,915 35.5%

*All figures are correct as of July 31st 2014